TCS PIM-1 1, 97%, a potent and selective ATP-competitive Pim-1 kianse inhibitor

Name: TCS PIM-1 1, 97%, a potent and selective ATP-competitive Pim-1 kianse inhibitor | 491871-58-0
Brand: J&K Chemical
SKU: JK2286711_50_MG
Price: 535.8 USD
Availability: OutOfStock

Cat. No JK2286711_50_MG

Vendor: J&K Chemical

Product Information

Product Name

TCS PIM-1 1, 97%, a potent and selective ATP-competitive Pim-1 kianse inhibitor

Brand Name

J&K

Product Number

2286711

CAS

491871-58-0

SDS Document

View/Download

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

1235170

Safety Information

Storage Condition

Freezer -20℃

References Data Source From Pubchem

BindingDB in 2024: a FAIR knowledgebase of protein-small molecule binding data

Publication Name: Nucleic Acids Research

Publication Date: 2024-11-22

DOI: 10.1093/nar/gkae1075

Synthesis and docking studies of pyran, pyridine and thiophene derivatives and their antitumor evaluations against cancer, hepatocellular carcinoma and cervical carcinoma cell lines

Publication Name: Journal of the Iranian Chemical Society

Publication Date: 2023-06-05

DOI: 10.1007/s13738-023-02793-y

High-Content Screening of Eukaryotic Kinase Inhibitors Identify CHK2 Inhibitor Activity Against Mycobacterium tuberculosis

Publication Name: Frontiers in Microbiology

Publication Date: 2020-09-18

DOI: 10.3389/fmicb.2020.553962

Potential Use of Selective and Nonselective Pim Kinase Inhibitors for Cancer Therapy

Publication Name: Journal of Medicinal Chemistry

Publication Date: 2012-09-04

DOI: 10.1021/jm3009234

Discovery of colon tumor cell growth inhibitory agents through a combinatorial approach

Publication Name: European Journal of Medicinal Chemistry

Publication Date: 2010-01

DOI: 10.1016/j.ejmech.2009.09.029

TCS PIM-1 1, 97%, a potent and selective ATP-competitive Pim-1 kianse inhibitor

Product Information

General Information

Safety Information

References Data Source From Pubchem

BindingDB in 2024: a FAIR knowledgebase of protein-small molecule binding data

Synthesis and docking studies of pyran, pyridine and thiophene derivatives and their antitumor evaluations against cancer, hepatocellular carcinoma and cervical carcinoma cell lines

High-Content Screening of Eukaryotic Kinase Inhibitors Identify CHK2 Inhibitor Activity Against Mycobacterium tuberculosis

Potential Use of Selective and Nonselective Pim Kinase Inhibitors for Cancer Therapy

Discovery of colon tumor cell growth inhibitory agents through a combinatorial approach